Becton Dickinson & Co (BDX) stock
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3021% above fair value
$218.03+2.32 (+1.08%)
Close on Nov 13, 2026Market cap $59.39BP/E 65.9Yield 1.91%
Becton Dickinson total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Becton Dickinson's total debt was $16.81B at Jun 30, 2026. For fiscal 2025 it was $19.18B, down 4.6% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $21.50B in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $19.18B | -4.6% |
| FY2024 | Sep 30, 2024 | $20.11B | +26.6% |
| FY2023 | Sep 30, 2023 | $15.88B | -1.2% |
| FY2022 | Sep 30, 2022 | $16.07B | -8.8% |
| FY2021 | Sep 30, 2021 | $17.61B | -1.8% |
| FY2020 | Sep 30, 2020 | $17.93B | -7.5% |
| FY2019 | Sep 30, 2019 | $19.39B | -9.8% |
| FY2018 | Sep 30, 2018 | $21.50B | +13.9% |
| FY2017 | Sep 30, 2017 | $18.87B | +63.4% |
| FY2016 | Sep 30, 2016 | $11.55B | -9.9% |
| FY2015 | Sep 30, 2015 | $12.82B | +222.9% |
| FY2014 | Sep 30, 2014 | $3.97B | +0.0% |
| FY2013 | Sep 30, 2013 | $3.97B | -4.7% |
| FY2012 | Sep 30, 2012 | $4.17B | +53.2% |
| FY2011 | Sep 30, 2011 | $2.72B | +60.2% |
| FY2010 | Sep 30, 2010 | $1.70B | -10.2% |
| FY2009 | Sep 30, 2009 | $1.89B | +839.5% |
| FY2008 | Sep 30, 2008 | $201.31M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $16.81B | -13.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $17.28B | -10.3% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $19.54B | +4.2% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $19.18B | -4.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $19.34B | +0.1% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $19.27B | +7.0% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $18.76B | +16.4% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $20.11B | +26.6% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $19.32B | +15.1% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $18.01B | -1.2% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $16.11B | -2.1% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $15.88B | -1.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $16.78B | +2.5% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $18.22B | -2.2% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $16.46B | -5.6% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $16.07B | -8.8% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $16.37B | -7.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $18.64B | +5.2% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $17.42B | -2.2% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $17.61B | -1.8% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $17.73B | -5.3% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $17.72B | -16.3% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $17.82B | -8.2% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $17.93B | -7.5% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $18.72B | -7.3% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $21.17B | +2.7% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $19.41B | -7.9% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $19.39B | -9.8% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $20.18B | -9.3% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $20.61B | -9.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $21.07B | -7.6% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $21.50B | +13.9% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $22.25B | +17.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $22.79B | +121.1% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $22.80B | +106.9% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $18.87B | +63.4% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $19.02B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $10.31B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $11.02B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $11.55B | – |
See a number that looks wrong?